Amicus Therapeutics (FOLD)

4.91 -0.08  -1.60%  May 29, 11:48AM Go Pro
You must be signed in to use watchlists.
Sign In or Register
Watch this stock

Amicus Therapeutics Altman Z-Score: -0.192

Get Interactive Chart for

View FOLD Altman Z-Score with YCharts Pro.




Start My 14-Day Free Trial We respect your privacy. We will never share your email address.
document.write('');

Access these YCharts Pro features:

  • Export any data you want
  • Save any chart as an image
  • Utilize advanced screener power
  • View 30 years of financial history
  • over 90 advanced calculations
  • Enjoy an advertising free experience
and much more...

FOLD Altman Z-Score Rankings

Overall 9th percentile 3224 of 3549
Sector 22nd percentile 334 of 433 in Healthcare
Industry 42nd percentile 69 of 120 in Biotechnology

FOLD Altman Z-Score Range, Past 5 Years

Minimum -4.923 Dec 2011
Maximum 2.629 Dec 2009
Average -0.5549

About Altman Z-Score

CAUTION: The Altman Z-Score is meant to be applied only to manufacturing firms that are near bankruptcy. It was not based on a sample including non-manufacturing firms (service firms, banks, etc.). Use it at your own risk with those companies, but beware that bankruptcy probabilities may be misstated.

The Altman Z-Score helps investors to gauge the probability of a company going bankrupt. Generally, firms with a score above 3.00 have a low probability of bankruptcy, and those with a Z-Score of less than 1.81 have a relatively high probability of bankruptcy.

Note that this is a probabilistic model, so it will not classify perfectly.

The score was first published in a 1968 paper by Edward Altman titled "Financial Ratios, Discriminant Analysis and the Prediction of Corporate Bankruptcy."

Altman re-tested the model in a 2000 paper titled "Predicting financial distress of companies: Revisiting the Z-score and Zeta models". The paper showed that the model still had utility for looking at manufacturers, though the number of misclassifications did increase over time.
Learn More

You may also be interested in these FOLD related companies

Display in Live Stream: Done
Options

FOLD News

$FOLD http://stks.co/40of
about 2 hours ago by Engi
10 biotech securities will be added to the Nasdaq biotech index on May 21: $CERS $CLDX $FOLD $INFI $JAZZ $OMER $OREX $PCRX $RPTP $TSRX
about 14 days ago by abubnic
Listen to $FOLD Q1 2012 earnings call - live at 05:00 PM, ondemand after - http://stks.co/3mFn
about 19 days ago by earningscast
$FOLD http://stks.co/3Tqh
about 35 days ago by Engi
$FOLD http://stks.co/3Lqx Long setup. Bullish engulfing. 200MA support.
about 44 days ago by VexTrades
$FOLD--Some huge insider buys just came through at 5.70. Do your own research. This looks like a stock offering, but insiders are buying.
about 81 days ago by MicroInsider
$FOLD forms bearish "Head and Shoulders Top" chart pattern. http://stks.co/2hZy
about 83 days ago by RecogniaEvents
$ECTE i see great potential in this one. A skin glucose monitor with no sticks!! Also long $FOLD for a long term play...
about 87 days ago by Stuckinstock
$FOLD Announces Proposed Public Offering of Common Stock; No Amount Given
about 89 days ago by Benzinga
Listen to $FOLD Q4 2011 earnings call (EPS -0.25 vs est -0.37) - live at 05:00 PM, ondemand after - http://stks.co/2Nmy
about 106 days ago by earningscast
$fold,,double bottom 6.93
about 106 days ago by teevee
10:50EST $FOLD Up 8% for the day. Reporting Earnings Today. http://stks.co/2NKe #tradeideas #stocks #investing #earnings
about 106 days ago by TradeIdeas1
$FOLD Presents Preclinical Studies for Gaucher Disease; AVI BioPharma Results From Phase I Clinical Trial. http://stks.co/2LHx
about 109 days ago by abubnic
$FOLD hod on deck
about 133 days ago by tradueruski
$FOLD hod pop
about 133 days ago by tradueruski
$FOLD filed latest Quarterly Report http://stks.co/vVr
about 209 days ago by MarketBrief
$FOLD filed latest Proxy Statement with the SEC (Form DEF 14A) http://stks.co/nqC
about 216 days ago by MarketBrief
$FOLD http://chart.ly/o5dekj2 long setup
about 274 days ago by stt2318
$FOLD $6.01 Crowley John F director officer (Executive Chairman) P 20,000 @ $6.04 amnt $120,800 proc'd ($600) 6/17/2011
about 343 days ago by canarionyc
$FOLD $7.56 Valenzano Ken officer (VP, Pharmacology & Biology) S 2,250 @ $7.50 amnt $16,875 proc'd ($135) 5/24/2011
about 370 days ago by canarionyc
$FOLD $30m shelf, max px $4.33
about 504 days ago by canarionyc
Register for BioNJ's annual meeting held 1/27/11, featured speaker J. Crowley, Amicus $FOLD CEO. Register at http://bit.ly/hxEerO #BioNJADM
about 515 days ago by MDBpartners
Best Stock List recommended $FOLD -Amicus Therapeutics, Inc. on 10/25/2010 16:00:00 and has gained 4.13%! $SPY http://bit.ly/gvoEjM
about 516 days ago by Tieler
Best Stock List recommended $FOLD -Amicus Therapeutics, Inc. on 10/25/2010 16:00:00 and has gained 4.13%! $SPY http://bit.ly/hLiIKn
about 516 days ago by Tieler

Recent Quotes

Symbol Price Chg Chg % Market Cap
FOLD 4.91 -0.08 -1.60% 222.80M
FOH 0.37 +0.00 +0.00% 14.40M
FOF 12.20 +0.11 +0.91%
FOE 4.64 +0.06 +1.31% 396.49M
FNSR 15.08 +0.49 +3.36% 1.325B
FLY 12.35 +0.03 +0.24% 316.01M
FLXS 20.04 +0.05 +0.25% 135.13M
FLT 38.37 -0.09 -0.23% 3.181B
FLR 50.40 +0.70 +1.41% 8.422B
FLOW 3.05 -0.02 -0.65% 146.93M
You must be signed in to use watchlists.
Sign In or Register
Create Watchlist from Stock Quotes
Close